Rubnitz JE - Search Results

1

Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.

Brown PA, Wieduwilt M, Logan A, DeAngelo DJ, Wang ES, Fathi A, Cassaday RD, Litzow M, Advani A, Aoun P, Bhatnagar B, Boyer MW, Bryan T, Burke PW, Coccia PF, Coutre SE, Jain N, Kirby S, Liu A, Massaro S, Mattison RJ, Oluwole O, Papadantonakis N, Park J, Rubnitz JE, Uy GL, Gregory KM, Ogba N, Shah B. Brown PA, et al. Among authors: rubnitz je. J Natl Compr Canc Netw. 2019 May 1;17(5):414-423. doi: 10.6004/jnccn.2019.0024. J Natl Compr Canc Netw. 2019. PMID: 31085755 Review.

2

Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML. Rubnitz JE, et al. Blood. 1994 Jul 15;84(2):570-3. Blood. 1994. PMID: 8025282 Free article.

3

Recent advances in the biology and treatment of childhood acute lymphoblastic leukemia.

Rubnitz JE, Pui CH. Rubnitz JE, et al. Curr Opin Hematol. 1997 Jul;4(4):233-41. doi: 10.1097/00062752-199704040-00003. Curr Opin Hematol. 1997. PMID: 9260050 Review.

4

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia.

Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D. Coustan-Smith E, et al. Among authors: rubnitz je. Lancet. 1998 Feb 21;351(9102):550-4. doi: 10.1016/S0140-6736(97)10295-1. Lancet. 1998. PMID: 9492773

5

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome.

Gruhn B, Hongeng S, Yi H, Hancock ML, Rubnitz JE, Neale GA, Kitchingman GR. Gruhn B, et al. Among authors: rubnitz je. Leukemia. 1998 May;12(5):675-81. doi: 10.1038/sj.leu.2400985. Leukemia. 1998. PMID: 9593264 Clinical Trial.

6

Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia.

Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, Head DR, Relling MV, Ribeiro RC, Rubnitz JE, Kun LE, Evans WE. Pui CH, et al. Among authors: rubnitz je. Blood. 1998 Jul 15;92(2):411-5. Blood. 1998. PMID: 9657739 Free article.

7

Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.

Rubnitz JE, Relling MV, Harrison PL, Sandlund JT, Ribeiro RC, Rivera GK, Thompson SJ, Evans WE, Pui CH. Rubnitz JE, et al. Leukemia. 1998 Aug;12(8):1176-81. doi: 10.1038/sj.leu.2401098. Leukemia. 1998. PMID: 9697870 Clinical Trial.

8

Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup.

Rubnitz JE, Behm FG, Wichlan D, Ryan C, Sandlund JT, Ribeiro RC, Rivera GK, Hancock ML, Relling MV, Evans WE, Pui CH, Downing JR. Rubnitz JE, et al. Leukemia. 1999 Jan;13(1):19-21. doi: 10.1038/sj.leu.2401257. Leukemia. 1999. PMID: 10049054

9

Sex differences in prognosis for children with acute lymphoblastic leukemia.

Pui CH, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar A, Evans WE. Pui CH, et al. Among authors: rubnitz je. J Clin Oncol. 1999 Mar;17(3):818-24. doi: 10.1200/JCO.1999.17.3.818. J Clin Oncol. 1999. PMID: 10071272

10

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, Sandlund JT, Rivera GK, Rubnitz JE, Ribeiro RC, Pui CH, Campana D. Coustan-Smith E, et al. Among authors: rubnitz je. Blood. 2000 Oct 15;96(8):2691-6. Blood. 2000. PMID: 11023499 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page